It has been demonstrated that VEGF inhibition causes a reduction in eNOS expression, which in turn results in a reduction in NO production19, and that this phenomenon is connected to the induction of hypertension, one of the most frequent dose-limiting toxicities of VEGF inhibitors20. The gene discussed is NOS3; the disease is Hypertension.